Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Kyobu Geka. the Japanese Journal of Thoracic Surgery|February 2, 2023
[Experience with a New Negative Pressure Incisional Wound Management System in Cardiac Surgery]Yoshikazu Kawazu, Yuka Ito, Ryo Imada, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|March 28, 2025
Job Stress, Psychological Distress, and Menstruation-Related Symptoms in Female Workers: A Cross-Sectional StudyNatsu Sasaki, Kazuhiro Watanabe, Miho Egawa, et al.
PCN Reports : Psychiatry and Clinical Neurosciences|March 10, 2026
The association of workplace psychosocial factors on premenstrual dysphoric disorder: A six-month prospective study on Japanese female workersMako Iida, Kazuhiro Watanabe, Miho Egawa, et al.
Neuropsychopharmacology Reports|March 6, 2026
Association Between Pregnancy Hope and Premenstrual Dysphoric Disorder Among Female Workers: A Cross-Sectional Online Survey in JapanYuka Ito, Natsu Sasaki, Yoshiaki Kanamori, et al.
Cancer Management and Research|February 25, 2021
Antiemetic Efficacy of Adding Olanzapine 5 mg to Aprepitant, Palonosetron and Dexamethasone-Sparing After Day Two for Cancer Patients Receiving Anthracycline and CyclophosphamideMarii Suehiro, Yasuyuki Kojima, Masaki Takahashi, et al.
Sangyo Eiseigaku Zasshi = Journal of Occupational Health|May 25, 2025
[Introducing a participatory workplace environmental improvement program by a part-time occupational health physician: Barriers, facilitators, and implementation strategies]Sawako Kamo, Toru Yoshikawa, Yuka Ito, et al.
DEN Open|May 2, 2024
Endoscopic assessment of the J pouch in ulcerative colitis: A narrative reviewShintaro Akiyama, Edward L Barnes, Tsubasa Onoda, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 8, 2017
A Randomized, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Adding Omarigliptin to Antihyperglycemic Therapies in Japanese Patients with Type 2 Diabetes and Inadequate Glycemic ControlIra Gantz, Taro Okamoto, Yuka Ito, et al.
Diabetes, Obesity & Metabolism|April 28, 2017
A randomized, placebo- and sitagliptin-controlled trial of the safety and efficacy of omarigliptin, a once-weekly dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetesIra Gantz, Taro Okamoto, Yuka Ito, et al.
The FEBS Journal|June 24, 2011
Glutamine stimulates the gene expression and processing of sterol regulatory element binding proteins, thereby increasing the expression of their target genesJun Inoue, Yuka Ito, Satoko Shimada, et al.
Pageof 8